Lindsay A Md Rosenwald Fortress Biotech, Inc. (FBIO) insider trading activity

Lindsay A Md Rosenwald is PRESIDENT, CEO & CHAIRMAN of Fortress Biotech, Inc.. Currently has a direct ownership of 3.66 Million shares of FBIO, which is worth approximately $8.63 Million. The most recent transaction as insider was on Sep 23, 2024, when has been sold 763,359 shares (Common Stock, par value $0.001) at a price of $1.84 per share, resulting in proceeds of $1,404,580. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.66M

0% 3M change

40.8% 12M change

Total Value Held $8.63 Million

LINDSAY A MD ROSENWALD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 23 2024	BUY Open market or private purchase	$1,404,580 $1.84 p/Share	763,359 Added 17.27%	3,657,264 Common Stock, par valu...
Jul 11 2024	BUY Open market or private purchase	$37,400 $7.48 p/Share	5,000 Added 3.77%	127,500 SERIES A CUMULATIVE PE...
Jul 09 2024	BUY Open market or private purchase	$36,950 $7.39 p/Share	5,000 Added 3.92%	122,500 SERIES A CUMULATIVE PE...
Jul 08 2024	BUY Open market or private purchase	$36,750 $7.35 p/Share	5,000 Added 4.08%	117,500 SERIES A CUMULATIVE PE...
Jun 28 2024	BUY Open market or private purchase	$32,800 $1.64 p/Share	20,000 Added 0.69%	2,893,905 Common Stock, par valu...
May 16 2024	BUY Open market or private purchase	$17,600 $1.76 p/Share	10,000 Added 0.35%	2,873,905 Common Stock, par valu...
Jan 05 2024	BUY Open market or private purchase	$119,000 $2.38 p/Share	50,000 Added 1.72%	2,863,905 Common Stock, par valu...
Jan 01 2024	BUY Grant, award, or other acquisition	-	216,465 Added 7.14%	2,813,905 Common Stock, par valu...
Nov 14 2023	BUY Open market or private purchase	$2,664,775 $1.7 p/Share	1,567,515 Added 37.64%	2,597,440 Common Stock, par valu...
Sep 26 2023	BUY Open market or private purchase	$28,000 $0.28 p/Share	100,000 Added 0.64%	15,449,091 Common Stock, par valu...
Aug 18 2023	BUY Open market or private purchase	$93,400 $9.34 p/Share	10,000 Added 8.16%	112,500 SERIES A CUMULATIVE PE...
Aug 17 2023	BUY Open market or private purchase	$117,500 $11.75 p/Share	10,000 Added 8.89%	102,500 SERIES A CUMULATIVE PE...
Feb 10 2023	BUY Open market or private purchase	$2,011,975 $0.84 p/Share	2,395,209 Added 13.5%	15,349,091 Common Stock, par valu...
Jan 01 2023	BUY Grant, award, or other acquisition	-	1,219,294 Added 8.6%	12,953,882 Common Stock, par valu...
Dec 01 2022	BUY Open market or private purchase	$68,000 $0.68 p/Share	100,000 Added 0.85%	11,730,324 Common Stock, par valu...
Nov 30 2022	BUY Open market or private purchase	$2,800 $0.56 p/Share	5,000 Added 0.04%	11,630,324 Common Stock, par valu...
Oct 21 2022	BUY Open market or private purchase	$70,000 $0.7 p/Share	100,000 Added 0.85%	11,625,324 Common Stock, par valu...
Jun 01 2022	BUY Grant, award, or other acquisition	$3,112 $0.73 p/Share	4,264 Added 0.04%	11,734,588 Common Stock, par valu...
Jan 01 2022	BUY Grant, award, or other acquisition	-	1,102,986 Added 8.73%	11,525,324 Common Stock, par valu...
Dec 01 2021	BUY Grant, award, or other acquisition	$3,025 $2.42 p/Share	1,250 Added 0.01%	10,422,338 Common Stock, par valu...
Nov 16 2021	BUY Other acquisition or disposition	-	4,619 Added 0.04%	10,421,088 Common Stock, par valu...
Sep 30 2021	BUY Other acquisition or disposition	-	8,133 Added 0.08%	10,416,469 Common Stock, par valu...
Jun 01 2021	BUY Grant, award, or other acquisition	$2,996 $2.31 p/Share	1,297 Added 0.01%	10,408,336 Common Stock, par valu...
Jan 01 2021	BUY Grant, award, or other acquisition	-	1,030,339 Added 9.01%	10,407,039 Common Stock, par valu...
Dec 01 2020	BUY Grant, award, or other acquisition	$2,925 $2.34 p/Share	1,250 Added 0.01%	9,376,700 Common Stock, par valu...

Also insider at

CKPT

Checkpoint Therapeutics, Inc. Healthcare

Director

DERM

Journey Medical Corp Healthcare

Director

MBIO

MUSTANG BIO, INC. Healthcare

Director

ATXI

AVENUE THERAPEUTICS, INC. Healthcare

Director

LAM